Therefore, in these cases, a more extensive surgical treatment and a greater number of chemotherapy cycles could be indicated, after individualized evaluation of the risk factors.[28–30] This is also reflected in terms of OS, which in the literature is reported to be equal to 97% in cases of dysgerminoma, and 60% (P < .001) in nongerminomas.[31] In our experience, all cases of recurrence recorded showed a histology different from dysgerminoma, and high dosage of AFP in the only case evolved in exitus for disease. This evidence concerns the gene AFP and dysgerminoma.